ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 894,43
-0,15%
Dow Jones
44 556,04
0,30%
DAX
21 495,61
-0,07%
Brent Oil
75,16
-1,03%
Bitcoin
98 416,59
0,57%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Allergy Therapeutics Plc (AGY) Cours

Allergy Therapeutics Plc

Allergy Therapeutics Plc (AGY)

Argosy Minerals Inc
5,75
-0,75
( -11,54% )
Mis à jour : 09:00:25
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
5,75
Prix Achat
5,50
Prix Vente
6,00
Volume échangé
131 179
5,75 Fourchette du Jour 6,33
2,25 Plage de 52 semaines 7,71
Cap du marché
274,07M
Clôture Veille
6,50
Ouverture
5,75
Dernière Transaction
500
@
5.9
(UT)
Dernière heure de transaction
12:00:08
Volume financier
8 264p
VWAP
6,30
Volume moyen (3 m)
519 970
Actions en circulation
4 766 439 938
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,85
Bénéfice par action (BPA)
-0,01
Chiffre d'affairess
55,2M
Bénéfice net
-40,22M

À propos de Allergy Therapeutics Plc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.allergytherapeutics.com
Siège social
West Sussex, Gbr
Fondé
-
Allergy Therapeutics Plc est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker AGY. Le dernier cours de clôture d'Allergy Therapeutics était de 6,50p. Au cours de la dernière année, les actions de Allergy Therapeutics ont été négociées dans une fourchette de prix de 2,25p à 7,71p.

Allergy Therapeutics compte actuellement 4 766 439 938 actions en circulation. La capitalisation boursière d'Allergy Therapeutics est de £309,82 million. Allergy Therapeutics a un ratio cours/bénéfice (ratio PE) de -6.85.

AGY Dernières nouvelles

Plus de nouvelles

IN BRIEF: Allergy Therapeutics expects annual sales to rise on-year

ics PLC - Sussex, England-based biotechnology company - Expects revenue to rise by 1.1%, or by 4% at constant currency ...

28 Janvier 2025
Alliance News

Allergy Therapeutics PLC Half Year Trading update

Allergy Therapeutics PLC 28 January 2025   Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company" or the "Group")   Half Year Trading update for the six months ended 31 December...

28 Janvier 2025
RNS Regulatory News

Allergy Therapeutics PLC PDMR Dealing and Total Voting Rights

Allergy Therapeutics PLC 22 January 2025     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   Issue of 13 Ordinary Shares Purchase and Cancellation of Deferred Shares...

22 Janvier 2025
RNS Regulatory News

Allergy Therapeutics PLC PDMR Dealing and Total Voting Rights

Allergy Therapeutics PLC 22 January 2025     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   Issue of 13 Ordinary Shares Purchase and Cancellation of Deferred Shares...

22 Janvier 2025
RNS Regulatory News

Allergy Therapeutics PLC PDMR Dealing and Total Voting Rights

Allergy Therapeutics PLC 22 January 2025     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   Issue of 13 Ordinary Shares Purchase and Cancellation of Deferred Shares...

22 Janvier 2025
RNS Regulatory News

Allergy Therapeutics PLC Director/PDMR Shareholding

Allergy Therapeutics PLC 15 January 2025     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   PDMR Dealings   Issue of 687,500,000 Warrants     15 January 2025 - Allergy...

15 Janvier 2025
RNS Regulatory News

Allergy Therapeutics PLC Exercise of Options and Total Voting Rights

Allergy Therapeutics PLC 19 December 2024       Allergy Therapeutics plc   ("Allergy Therapeutics", or the "Group")   Exercise of Options and Total Voting Rights   19 December 2024 Allergy...

19 Décembre 2024
RNS Regulatory News

Allergy Therapeutics PLC Block Listing Interim Review

Allergy Therapeutics PLC 17 December 2024   Allergy Therapeutics plc   ("Allergy Therapeutics", "ATL" or the "Group")   Block Listing Interim Review     Name of applicant: ALLERGY THERAPEUTICS...

17 Décembre 2024
RNS Regulatory News

Allergy Therapeutics PLC Result of Annual General Meeting

Allergy Therapeutics PLC 16 December 2024     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group")   Result of Annual General Meeting     16 December 2024 Allergy Therapeutics plc...

16 Décembre 2024
RNS Regulatory News

Allergy Therapeutics PLC Positive Interim Data from PROTECT Trial

Allergy Therapeutics PLC 04 December 2024   Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group")   Allergy Therapeutics announces positive interim analysis data from the...

04 Décembre 2024
RNS Regulatory News
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1-14.81481481486.757.085.755138236.29504631DE
4-1.35-19.0140845077.17.715.754236197.07244488DE
120.751557.7155199706.39072486DE
260.9519.79166666674.87.713.884094285.66611001DE
523.4144.6808510642.357.712.256017364.39966526DE
156-20-77.669902912625.75260.855075333.48451895DE
260-5.5-48.888888888911.25400.854464279.01715993DE

AGY - Frequently Asked Questions (FAQ)

What is the current Allergy Therapeutics share price?
The current share price of Allergy Therapeutics is 5,75p
How many Allergy Therapeutics shares are in issue?
Allergy Therapeutics has 4 766 439 938 shares in issue
What is the market cap of Allergy Therapeutics?
The market capitalisation of Allergy Therapeutics is GBP 309,82M
What is the 1 year trading range for Allergy Therapeutics share price?
Allergy Therapeutics has traded in the range of 2,25p to 7,71p during the past year
What is the PE ratio of Allergy Therapeutics?
The price to earnings ratio of Allergy Therapeutics is -6,85
What is the cash to sales ratio of Allergy Therapeutics?
The cash to sales ratio of Allergy Therapeutics is 4,96
What is the reporting currency for Allergy Therapeutics?
Allergy Therapeutics reports financial results in GBP
What is the latest annual turnover for Allergy Therapeutics?
The latest annual turnover of Allergy Therapeutics is GBP 55,2M
What is the latest annual profit for Allergy Therapeutics?
The latest annual profit of Allergy Therapeutics is GBP -40,22M
What is the registered address of Allergy Therapeutics?
The registered address for Allergy Therapeutics is DOMINION WAY, WORTHING, WEST SUSSEX, BN14 8SA
What is the Allergy Therapeutics website address?
The website address for Allergy Therapeutics is www.allergytherapeutics.com
Which industry sector does Allergy Therapeutics operate in?
Allergy Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GFINGfinity Plc
0,0875p
(59,09%)
80,98M
XSGXeros Technology Group Plc
0,675p
(28,57%)
15,19M
IKAIlika Plc
34,00p
(25,93%)
951,05k
SYMESupply@me Capital Plc
0,0034p
(23,64%)
99,56M
STXShield Therapeutics Plc
3,40p
(19,30%)
9,8M
WBIWoodbois Limited
0,05p
(-39,39%)
405,56M
SCGLSealand Capital Galaxy Limited
3,75p
(-30,56%)
5,79M
KRPZKropz Plc
0,85p
(-26,09%)
128,73k
TRCThe Revel Collective Plc
0,175p
(-22,22%)
4,18M
PRDPredator Oil & Gas Holdings Plc
4,25p
(-22,02%)
21,65M
NTVONativo Resources Plc
0,0017p
(0,00%)
1,25B
WBIWoodbois Limited
0,05p
(-39,39%)
405,56M
OBDOxford Biodynamics Plc
0,575p
(15,00%)
295,77M
MSMNMosman Oil And Gas Limited
0,041p
(-5,75%)
211,11M
DKEDukemount Capital Plc
0,045p
(-1,10%)
167,21M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
AGY
Allergy Therapeutics
BIT
S31375
Societe Generale Effekten
BIT
NSCIT0231554
Austria 05 35 Flr Mtn
BIT
NSCIT2694866
Agricultural Pension Bank
BIT
KI
Ki
BOV
VALEO565
VALEO565 Ex:54,36
BIT
S29656
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces